The purpose of this study is to examine the impact of new cancer genetic counseling models that aim to increase patient engagement with the genetics team. To d…

BRCA1 MutationPOLD1 Gene MutationCDKN2A Mutation+19 more

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT05420064

Phase 2

Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer (BabyTEARS)

The goal of this research study is to evaluate the efficacy and safety of low-dose exemestane versus low-dose tamoxifen in post-menopausal women at high risk f…

Breast CancerDuctal CarcinomaEstrogen-receptor-positive Breast Cancer+4 more

~Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT07499999